Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group
Controversies exist about the definition and epidemiology of breakthrough cancer pain (BTcP), the pharmacological treatment options, drug dosing, and how to select the medications for BTcP among the new fentanyl products. Existing data were critically evaluated to provide recommendations by an exper...
Gespeichert in:
| Veröffentlicht in: | Supportive care in cancer 2016-02, Vol.24 (2), p.961-968 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 968 |
|---|---|
| container_issue | 2 |
| container_start_page | 961 |
| container_title | Supportive care in cancer |
| container_volume | 24 |
| creator | Mercadante, Sebastiano Marchetti, Paolo Cuomo, Arturo Mammucari, Massimo Caraceni, Augusto |
| description | Controversies exist about the definition and epidemiology of breakthrough cancer pain (BTcP), the pharmacological treatment options, drug dosing, and how to select the medications for BTcP among the new fentanyl products. Existing data were critically evaluated to provide recommendations by an expert group. An algorithm to diagnose BTcP should be used followed by a careful assessment. Fentanyl products provide efficacy and rapidity of action to counteract the temporal pattern of BTcP. The doses of opioids used for background pain should guide the choice of the doses of fentanyl products. The choice of fentanyl products should be based on individual clinical conditions. |
| doi_str_mv | 10.1007/s00520-015-2951-y |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1751995204</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A442890409</galeid><sourcerecordid>A442890409</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-dc239d88aa6db06decc461477d2d388c7bc397f5e4d9c57ad5f57cf16e1af8623</originalsourceid><addsrcrecordid>eNp1kV1vFCEYhYnR2G31B3hjSLxpL6bCAMOMd7XxY5Mm26R6TVh4Z0qdgRWY6l7432W79TMaLkg4zzm8cBB6RskpJUS-TISImlSEiqruBK22D9CCcsYqyVj3EC1Ix2nFmRAH6DClG0KolKJ-jA7qhrOWcrFA315H0J_ydQzzcI032nmsvcUuJ5yLkifw-RU20WVn9Igj3Dr4codEMGEqstXZBZ9w6PFydXmFj5dZj057vPImjGFwBl_uYq_meAvbEwxfNxAzHsqNmyfoUa_HBE_v9yP08e2bD-fvq4vVu-X52UVlBBO5sqZmnW1brRu7Jo0FY3hDuZS2tqxtjVwb1sleALedEVJb0QtpetoA1X3b1OwIHe9zNzF8niFlNblkYBy1hzAnRaWgXVf-khf0xV_oTZijL9PdUUzWUjS_qEGPoJzvQ47a7ELVGed12xFOukKd_oMqy8LkTPDQu3L-h4HuDSaGlCL0ahPdpONWUaJ2lat95apUrnaVq23xPL8feF5PYH86fnRcgHoPpCL5AeJvL_pv6nfUsban</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1751372756</pqid></control><display><type>article</type><title>Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Mercadante, Sebastiano ; Marchetti, Paolo ; Cuomo, Arturo ; Mammucari, Massimo ; Caraceni, Augusto</creator><creatorcontrib>Mercadante, Sebastiano ; Marchetti, Paolo ; Cuomo, Arturo ; Mammucari, Massimo ; Caraceni, Augusto ; IOPS MS study Group ; on behalf of the IOPS MS study Group</creatorcontrib><description>Controversies exist about the definition and epidemiology of breakthrough cancer pain (BTcP), the pharmacological treatment options, drug dosing, and how to select the medications for BTcP among the new fentanyl products. Existing data were critically evaluated to provide recommendations by an expert group. An algorithm to diagnose BTcP should be used followed by a careful assessment. Fentanyl products provide efficacy and rapidity of action to counteract the temporal pattern of BTcP. The doses of opioids used for background pain should guide the choice of the doses of fentanyl products. The choice of fentanyl products should be based on individual clinical conditions.</description><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-015-2951-y</identifier><identifier>PMID: 26438145</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Algorithms ; Analgesics, Opioid - administration & dosage ; Analgesics, Opioid - therapeutic use ; Breakthrough Pain - drug therapy ; Cancer ; Care and treatment ; Choice Behavior ; Epidemiology ; Ethnic Groups ; Evidence-based medicine ; Expert Testimony ; Fentanyl - administration & dosage ; Fentanyl - therapeutic use ; Humans ; Italy ; Medicine ; Medicine & Public Health ; Narcotics ; Neoplasms - drug therapy ; Nursing ; Nursing Research ; Oncology ; Opioids ; Pain ; Pain management ; Pain Measurement - methods ; Pain Medicine ; Rehabilitation Medicine ; Review Article ; Surveys ; Surveys and Questionnaires</subject><ispartof>Supportive care in cancer, 2016-02, Vol.24 (2), p.961-968</ispartof><rights>Springer-Verlag Berlin Heidelberg 2015</rights><rights>COPYRIGHT 2016 Springer</rights><rights>Springer-Verlag Berlin Heidelberg 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-dc239d88aa6db06decc461477d2d388c7bc397f5e4d9c57ad5f57cf16e1af8623</citedby><cites>FETCH-LOGICAL-c535t-dc239d88aa6db06decc461477d2d388c7bc397f5e4d9c57ad5f57cf16e1af8623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-015-2951-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-015-2951-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26438145$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mercadante, Sebastiano</creatorcontrib><creatorcontrib>Marchetti, Paolo</creatorcontrib><creatorcontrib>Cuomo, Arturo</creatorcontrib><creatorcontrib>Mammucari, Massimo</creatorcontrib><creatorcontrib>Caraceni, Augusto</creatorcontrib><creatorcontrib>IOPS MS study Group</creatorcontrib><creatorcontrib>on behalf of the IOPS MS study Group</creatorcontrib><title>Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><description>Controversies exist about the definition and epidemiology of breakthrough cancer pain (BTcP), the pharmacological treatment options, drug dosing, and how to select the medications for BTcP among the new fentanyl products. Existing data were critically evaluated to provide recommendations by an expert group. An algorithm to diagnose BTcP should be used followed by a careful assessment. Fentanyl products provide efficacy and rapidity of action to counteract the temporal pattern of BTcP. The doses of opioids used for background pain should guide the choice of the doses of fentanyl products. The choice of fentanyl products should be based on individual clinical conditions.</description><subject>Algorithms</subject><subject>Analgesics, Opioid - administration & dosage</subject><subject>Analgesics, Opioid - therapeutic use</subject><subject>Breakthrough Pain - drug therapy</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Choice Behavior</subject><subject>Epidemiology</subject><subject>Ethnic Groups</subject><subject>Evidence-based medicine</subject><subject>Expert Testimony</subject><subject>Fentanyl - administration & dosage</subject><subject>Fentanyl - therapeutic use</subject><subject>Humans</subject><subject>Italy</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Narcotics</subject><subject>Neoplasms - drug therapy</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Opioids</subject><subject>Pain</subject><subject>Pain management</subject><subject>Pain Measurement - methods</subject><subject>Pain Medicine</subject><subject>Rehabilitation Medicine</subject><subject>Review Article</subject><subject>Surveys</subject><subject>Surveys and Questionnaires</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kV1vFCEYhYnR2G31B3hjSLxpL6bCAMOMd7XxY5Mm26R6TVh4Z0qdgRWY6l7432W79TMaLkg4zzm8cBB6RskpJUS-TISImlSEiqruBK22D9CCcsYqyVj3EC1Ix2nFmRAH6DClG0KolKJ-jA7qhrOWcrFA315H0J_ydQzzcI032nmsvcUuJ5yLkifw-RU20WVn9Igj3Dr4codEMGEqstXZBZ9w6PFydXmFj5dZj057vPImjGFwBl_uYq_meAvbEwxfNxAzHsqNmyfoUa_HBE_v9yP08e2bD-fvq4vVu-X52UVlBBO5sqZmnW1brRu7Jo0FY3hDuZS2tqxtjVwb1sleALedEVJb0QtpetoA1X3b1OwIHe9zNzF8niFlNblkYBy1hzAnRaWgXVf-khf0xV_oTZijL9PdUUzWUjS_qEGPoJzvQ47a7ELVGed12xFOukKd_oMqy8LkTPDQu3L-h4HuDSaGlCL0ahPdpONWUaJ2lat95apUrnaVq23xPL8feF5PYH86fnRcgHoPpCL5AeJvL_pv6nfUsban</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Mercadante, Sebastiano</creator><creator>Marchetti, Paolo</creator><creator>Cuomo, Arturo</creator><creator>Mammucari, Massimo</creator><creator>Caraceni, Augusto</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20160201</creationdate><title>Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group</title><author>Mercadante, Sebastiano ; Marchetti, Paolo ; Cuomo, Arturo ; Mammucari, Massimo ; Caraceni, Augusto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-dc239d88aa6db06decc461477d2d388c7bc397f5e4d9c57ad5f57cf16e1af8623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Algorithms</topic><topic>Analgesics, Opioid - administration & dosage</topic><topic>Analgesics, Opioid - therapeutic use</topic><topic>Breakthrough Pain - drug therapy</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Choice Behavior</topic><topic>Epidemiology</topic><topic>Ethnic Groups</topic><topic>Evidence-based medicine</topic><topic>Expert Testimony</topic><topic>Fentanyl - administration & dosage</topic><topic>Fentanyl - therapeutic use</topic><topic>Humans</topic><topic>Italy</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Narcotics</topic><topic>Neoplasms - drug therapy</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Opioids</topic><topic>Pain</topic><topic>Pain management</topic><topic>Pain Measurement - methods</topic><topic>Pain Medicine</topic><topic>Rehabilitation Medicine</topic><topic>Review Article</topic><topic>Surveys</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mercadante, Sebastiano</creatorcontrib><creatorcontrib>Marchetti, Paolo</creatorcontrib><creatorcontrib>Cuomo, Arturo</creatorcontrib><creatorcontrib>Mammucari, Massimo</creatorcontrib><creatorcontrib>Caraceni, Augusto</creatorcontrib><creatorcontrib>IOPS MS study Group</creatorcontrib><creatorcontrib>on behalf of the IOPS MS study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mercadante, Sebastiano</au><au>Marchetti, Paolo</au><au>Cuomo, Arturo</au><au>Mammucari, Massimo</au><au>Caraceni, Augusto</au><aucorp>IOPS MS study Group</aucorp><aucorp>on behalf of the IOPS MS study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>24</volume><issue>2</issue><spage>961</spage><epage>968</epage><pages>961-968</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><abstract>Controversies exist about the definition and epidemiology of breakthrough cancer pain (BTcP), the pharmacological treatment options, drug dosing, and how to select the medications for BTcP among the new fentanyl products. Existing data were critically evaluated to provide recommendations by an expert group. An algorithm to diagnose BTcP should be used followed by a careful assessment. Fentanyl products provide efficacy and rapidity of action to counteract the temporal pattern of BTcP. The doses of opioids used for background pain should guide the choice of the doses of fentanyl products. The choice of fentanyl products should be based on individual clinical conditions.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>26438145</pmid><doi>10.1007/s00520-015-2951-y</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0941-4355 |
| ispartof | Supportive care in cancer, 2016-02, Vol.24 (2), p.961-968 |
| issn | 0941-4355 1433-7339 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1751995204 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Algorithms Analgesics, Opioid - administration & dosage Analgesics, Opioid - therapeutic use Breakthrough Pain - drug therapy Cancer Care and treatment Choice Behavior Epidemiology Ethnic Groups Evidence-based medicine Expert Testimony Fentanyl - administration & dosage Fentanyl - therapeutic use Humans Italy Medicine Medicine & Public Health Narcotics Neoplasms - drug therapy Nursing Nursing Research Oncology Opioids Pain Pain management Pain Measurement - methods Pain Medicine Rehabilitation Medicine Review Article Surveys Surveys and Questionnaires |
| title | Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A11%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Breakthrough%20pain%20and%20its%20treatment:%20critical%20review%20and%20recommendations%20of%20IOPS%20(Italian%20Oncologic%20Pain%20Survey)%20expert%20group&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Mercadante,%20Sebastiano&rft.aucorp=IOPS%20MS%20study%20Group&rft.date=2016-02-01&rft.volume=24&rft.issue=2&rft.spage=961&rft.epage=968&rft.pages=961-968&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-015-2951-y&rft_dat=%3Cgale_proqu%3EA442890409%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1751372756&rft_id=info:pmid/26438145&rft_galeid=A442890409&rfr_iscdi=true |